CRVS Annual Accounts Receivable
$26.00 K
-$562.00 K-95.58%
31 December 2023
Summary:
As of January 22, 2025, CRVS annual accounts receivable is $26.00 thousand, with the most recent change of -$562.00 thousand (-95.58%) on December 31, 2023. During the last 3 years, it has risen by +$26.00 thousand (+100.00%). CRVS annual accounts receivable is now -95.58% below its all-time high of $588.00 thousand, reached on December 31, 2022.CRVS Accounts Receivable Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
CRVS Quarterly Accounts Receivable
$70.00 K
+$35.00 K+100.00%
30 September 2024
Summary:
As of January 22, 2025, CRVS quarterly accounts receivable is $70.00 thousand, with the most recent change of +$35.00 thousand (+100.00%) on September 30, 2024. Over the past year, it has increased by +$59.00 thousand (+536.36%). CRVS quarterly accounts receivable is now -88.10% below its all-time high of $588.00 thousand, reached on December 31, 2022.CRVS Quarterly Accounts Receivable Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
CRVS Accounts Receivable Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -95.6% | +536.4% |
| 3 y3 years | +100.0% | -88.1% |
| 5 y5 years | - | -88.1% |
CRVS Accounts Receivable High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -95.6% | at low | -88.1% | |
| 5 y | 5-year | -95.6% | -88.1% | ||
| alltime | all time | -95.6% | -88.1% |
Corvus Pharmaceuticals Accounts Receivable History
| Date | Annual | Quarterly |
|---|---|---|
| Sept 2024 | - | $70.00 K(+100.0%) |
| June 2024 | - | $35.00 K(+34.6%) |
| Mar 2024 | - | $26.00 K(0.0%) |
| Dec 2023 | $26.00 K(-95.6%) | $26.00 K(+136.4%) |
| Sept 2023 | - | $11.00 K(>+9900.0%) |
| June 2023 | - | $0.00(-100.0%) |
| Mar 2023 | - | $429.00 K(-27.0%) |
| Date | Annual | Quarterly |
|---|---|---|
| Dec 2022 | $588.00 K(+16.0%) | $588.00 K(+16.9%) |
| Sept 2022 | - | $503.00 K(+34.9%) |
| June 2022 | - | $373.00 K(0.0%) |
| Mar 2022 | - | $373.00 K(-26.4%) |
| Dec 2021 | $507.00 K(>+9900.0%) | $507.00 K(+83.7%) |
| Sept 2021 | - | $276.00 K(>+9900.0%) |
| Dec 2020 | $0.00 | $0.00 |
FAQ
- What is Corvus Pharmaceuticals annual accounts receivable?
- What is the all time high annual accounts receivable for Corvus Pharmaceuticals?
- What is Corvus Pharmaceuticals annual accounts receivable year-on-year change?
- What is Corvus Pharmaceuticals quarterly accounts receivable?
- What is the all time high quarterly accounts receivable for Corvus Pharmaceuticals?
- What is Corvus Pharmaceuticals quarterly accounts receivable year-on-year change?
What is Corvus Pharmaceuticals annual accounts receivable?
The current annual accounts receivable of CRVS is $26.00 K
What is the all time high annual accounts receivable for Corvus Pharmaceuticals?
Corvus Pharmaceuticals all-time high annual accounts receivable is $588.00 K
What is Corvus Pharmaceuticals annual accounts receivable year-on-year change?
Over the past year, CRVS annual accounts receivable has changed by -$562.00 K (-95.58%)
What is Corvus Pharmaceuticals quarterly accounts receivable?
The current quarterly accounts receivable of CRVS is $70.00 K
What is the all time high quarterly accounts receivable for Corvus Pharmaceuticals?
Corvus Pharmaceuticals all-time high quarterly accounts receivable is $588.00 K
What is Corvus Pharmaceuticals quarterly accounts receivable year-on-year change?
Over the past year, CRVS quarterly accounts receivable has changed by +$59.00 K (+536.36%)